Accreditation NO: G2019006
This activity has been accredited for 1 hour of Group 1 CPD (or 1 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to 1 hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities (Multiple choice final quiz).
This course serves as an introduction to medicinal cannabis for Pharmacists and aims to provide a basic understanding of the therapeutic properties of medicinal cannabis and its potential application in chronic pain management, palliative care, multiple sclerosis, CINV, and epilepsy.
This course aims to provide Pharmacists with a basic understanding of the endocannabinoid system, pharmacology, mechanisms of action, acute toxicity and safety ratio of cannabis, patient considerations, pharmacokinetics, dosing, and titration.
This course is designed for:
About the Instructors
Dr. Teresa Towpik
Chief Medical Officer | MEDIHUANNA
Dr Towpik is an Australian GP and an advocate of medicinal cannabis. She has been extensively studying the therapeutic properties of cannabis and applying it in her practice with promising results. Her main focus is the management of chronic debilitating pain.
Cannabis is becoming widely accepted and requested by patients. Now, there is a growing need for doctors to obtain practical skills and knowledge to prescribe it effectively and safely. Recognising this need, Dr Towpik founded MediHuanna, an organisation providing accredited cannabis education for Health Professionals. She is also the Chief Medical Officer and Director of Compass Clinics Australia, a soon to launch lifestyle clinic with a focus on medicinal cannabis treatment.
Conflict of interest disclosure: Dr Towpik is the Chief Medical Officer, Director and a shareholder of MediHuanna as well as Compass Clinics Australia Pty Ltd (Lifestyle medical clinic with a focus on medicinal cannabis treatment).
Chief Pharmacist | HEALTH HOUSE INTERNATIONAL
Paul is a registered Australian and UK pharmacist. His company Health House was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Over the last 30 years he has owned several retail pharmacies and worked both in Australia and the UK.
In the last 3 years he has focussed on researching medicinal cannabis and has been to conferences, grow and manufacturing facilities and spoken to patients and prescribers in the US, Canada, Israel and recently South America. www.healthhouse.com.au
Conflict of interest disclosure: Paul Mavor is a director and major shareholder of Health House International Pty Ltd (medicinal cannabis wholesaler).